Skip to main content
Clinical Trials/JPRN-jRCTs032190123
JPRN-jRCTs032190123
Completed
Phase 1

Efficacy of maxillary sinus augmentation using long-term absorbable GBR membrane(GMEM-B2)

MUNAKATA MOTOHIRO0 sites25 target enrollmentOctober 28, 2019

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
MUNAKATA MOTOHIRO
Enrollment
25
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
October 28, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
MUNAKATA MOTOHIRO

Eligibility Criteria

Inclusion Criteria

  • 1\.20 years old or older and less than 65 years old
  • 2\.Non\-smoker
  • 3\.Patients with bone mass less than 4 mm planned implant placement site according to CT examination results
  • 4\.Patients obtained written informed consent about participation in this study

Exclusion Criteria

  • 1\.Removable prosthetics
  • 2\.Patient with respiratory disease
  • 3\.Osteoporosis, severe diabetes, rheumatoid arthritis, bone metabolism diseases such as taking steroids or BP drugs and those taking medications
  • 4\.Patients with alcohol and drug addiction, mental illness
  • 5\.Patients with cyst or tumor / inflammation in maxillary sinus on CT examination result
  • 6\.Patients who had got the radiation therapy.
  • 7\.Patients with heart disease, blood disease, collagen disease
  • 8\.Patients with kidney failure or dialysis
  • 9\.Patients who are pregnant and lactation period
  • 10\.Patients with a history of hypersensitivity or allergy to copolymer of e\-caprolactone and L\-lactide

Outcomes

Primary Outcomes

Not specified

Similar Trials